Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/1993
10/26/1993CA1323578C Single-phase composition containing a perfluorinated oil and one or more surfactant(s), useful as an excipient for cosmetic and dermatologic formulations, as well as for biomedical applications
10/20/1993EP0566158A1 The use of alpha-1-antitrypsin mutants in the manufacture of medicaments, and therapeutic formulations using mutants and their preparation
10/20/1993EP0565896A2 Derivatives of aspartic acid, preparation and use thereof
10/20/1993EP0565634A1 Angiotensin ii receptor blocking compositions
10/20/1993EP0565582A1 Novel csaids
10/20/1993EP0458930B1 STABILIZATION OF GLYCOSYLIZED t-PA
10/20/1993EP0356484B1 Process for preparation of aloe products
10/19/1993US5254672 Synthetic peptides which contain sequences from factor VIIa, and the use thereof
10/19/1993US5254569 (Amidomethyl)nitrogen heterocyclic analgesics
10/19/1993US5254564 Substituted isoquinoline compounds, pharmaceutical composition and method of use in treating pain in mammals
10/19/1993US5254546 Fused aryl substituted imidazole angiotensin II receptor inhibitors
10/19/1993US5254350 Using a metal chelator
10/19/1993CA1323373C .beta.-d-phenyl-thioxylosides, their method of preparation and their useas therapeutics
10/19/1993CA1323308C Lignosulfonate based pharmacologic agent with anti- coagulant and anti-thrombotic activity
10/14/1993WO1993020197A1 Stem cell proliferation factor
10/14/1993WO1993020093A1 Hybrid human/porcine factor viii
10/14/1993WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors
10/14/1993WO1993019805A1 Fibrin sealant delivery method
10/14/1993WO1993019737A1 A pharmaceutical composition containing a defined lipid system
10/14/1993CA2117495A1 Fibrin sealant delivery method
10/13/1993EP0565396A1 1-(2-arylsulfonylamino)-1-oxoethyl)-piperidine derivatives, their preparation and use in therapy
10/13/1993EP0564495A1 Tissue factor based prothrombin time reagent
10/12/1993US5252715 Process for the preparation of a pasteurized and iron-free human transferrin and the use thereof
10/12/1993US5252601 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
10/12/1993US5252479 Safe vector for gene therapy
10/12/1993US5252339 Pharmaceutical compositions containing orally absorbable glycosamimoglycans
10/11/1993CA2093575A1 Human antithrombin iii mutant
10/06/1993EP0563302A1 Method and apparatus for granulation
10/06/1993EP0563286A1 Novel csaids
10/06/1993EP0563128A1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines
10/06/1993EP0314749B1 Haemoglobin complexes
10/06/1993CN1076928A 1-(2-arylsulfon amido)-1-oxyethyl) piperidine derivatives and their preparation and use in therapy
10/05/1993US5250679 Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
10/05/1993US5250665 Specifically β-β cross-linked hemoglobins and method of preparation
10/01/1993CA2092867A1 1-¬2-(arylsulfonylamine)-1-oxoethyl|piperidine derivatives, their preparation and therapeutic applications
09/1993
09/30/1993WO1993019089A2 Oxygen carrier
09/30/1993WO1993019046A1 Novel sulfonamide fibrinogen receptor antagonists
09/30/1993WO1993018782A1 Glycosylation-mediated inhibition of factor x
09/30/1993WO1993018648A1 In vitro-derived human neutrophil precursor cells
09/30/1993CA2132518A1 Glycosylation-mediated inhibition of factor x
09/30/1993CA2132345A1 Oxygen carrier
09/30/1993CA2109729A1 In vitro-derived human neutrophil precursor cells
09/29/1993EP0563023A1 Use of tissue factor pathway inhibitor for the manufacture of a medicament for use in a method of inhibiting microvascular thrombosis
09/29/1993EP0562512A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines
09/29/1993EP0562439A1 Triazolopyridazines as antioasthmatics
09/29/1993EP0561960A1 Leukemia inhibitory factor receptors
09/29/1993EP0561907A1 Proteins with changed epitopes and methods for the production thereof
09/29/1993CN1076691A Sulfonamido-and sulfonamidocarbonyl-pyridin-2-carbonsaureamide as well as pyridin-n-oxide thereof
09/29/1993CN1076690A Sulfonamidocarboxamides
09/28/1993US5248785 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
09/28/1993US5248697 For treatment of radiation associated oxidative damage in tissue
09/25/1993CA2092276A1 Sulfonamido- and sulfonamidocarbonylpyridine -2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
09/22/1993EP0561496A2 cDNAs encoding the gastrin and CCK-B receptors
09/22/1993EP0561427A1 Monoclonal antibodies to new factor VIII coagulant polypeptides
09/22/1993EP0560913A1 Bifunctional inhibitors of thrombin and platelet activation
09/22/1993EP0423151B1 Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical compositions containing them
09/21/1993US5246957 N-imidazolyl derivatives of substituted indole
09/21/1993US5246956 N-imidazolyl derivatives of substituted alkoxyimino tetrahydronaphthalenes and chromans having antithromboxane a2 activity
09/21/1993US5246699 Maturation of hemopoietic cells
09/21/1993CA1322370C Phosphate ester derivatives, their preparation and their therapeutic use
09/21/1993CA1322367C Thienotriazolodiazepine compounds and pharmaceutical uses thereof
09/19/1993CA2091874A1 Triazolopyridazine compounds, their production and use
09/16/1993WO1993018141A1 Thrombin receptor antagonists
09/16/1993WO1993018060A1 New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
09/16/1993WO1993018057A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
09/16/1993WO1993017684A2 Enantiomeric hydroxylated xanthine compounds
09/16/1993CA2131389A1 Thrombin receptor antagonists
09/16/1993CA2131367A1 New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
09/15/1993EP0560730A2 New derivatives of beta-amino acids with anti-thrombotic activity
09/15/1993EP0560407A1 Pharmaceutically active compounds
09/15/1993EP0458950B1 Stabilization of k2p pro
09/15/1993CN1076200A New derivatives of beta-amino acids
09/15/1993CN1076199A 新的肽衍生物 New peptide derivatives
09/14/1993US5245014 Method for isolating factors viii from plasma by gel filtration chromatography under group separation conditions
09/14/1993US5244898 Benzoheterocyclic compounds
09/14/1993CA1322165C Method for treating iron overload
09/14/1993CA1322163C Plasminogen activator production
09/14/1993CA1322158C Uses of recombinant colony stimulating factor-1
09/11/1993CA2091292A1 New derivatives of .beta.-amino acids
09/09/1993DE4207254A1 4-oxo-2-thioxoimidazolidin-derivate 4-oxo-2-thioxoimidazolidin-derivatives
09/08/1993EP0559632A2 Method of producing tissue factor pathway inhibitor
09/08/1993EP0559046A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors
09/08/1993EP0558961A2 Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them
09/08/1993EP0558645A1 Erythrocytes and thrombo-erythrocytes as target specific agents
09/08/1993CN1075988A 多元溶剂清洗系统 Multiple solvent cleaning system
09/08/1993CN1075959A Pyrazole derivatives processes for preparation thereof and pharmaceutical composition comprising the same
09/07/1993US5243094 Derivatives of long chain fatty alcohols, their uses, particularly as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing them
09/07/1993US5242942 Anticonvulsant fructopyranose cyclic sulfites and sulfates
09/07/1993US5242810 Bifunctional inhibitors of thrombin and platelet activation
09/07/1993US5242688 Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
09/06/1993CA2091024A1 Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
09/02/1993WO1993017122A1 Protein with novel pharmacological characteristic
09/02/1993WO1993016709A1 Therapeutic domains of von willebrand factor
09/02/1993WO1993016691A1 New use of omega-3-fatty acids
09/02/1993WO1993016688A1 Facilitated oxygen delivery in conjunction with hemodilution
09/02/1993CA2117535A1 New use of omega-3-fatty acids
09/01/1993EP0558258A1 N-isoxazole-naphthylsulfonamide derivatives and their use as endothelin antagonists
09/01/1993EP0558213A1 Process for preparing neotrehalose, and its uses
09/01/1993EP0558062A2 Phenoxyacetic acid derivatives and pharmaceutical compositions containing them
09/01/1993EP0557787A1 Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments
1 ... 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 ... 671